Study: Three X-Chromosome Genes May Help Control Sex Determination in Cannabis

A new study published in New Phytologist identifies three closely linked genes on the X chromosome that may help control whether Cannabis sativa plants develop as male, female or monoecious. Researchers from University College Dublin and Université Paris-Saclay used genetic mapping, transcriptomic analysis and X-Y chromosome comparisons to examine the biological basis of sex determination …

Continue reading

TerrAscend Reports $65.5 Million in Q1 Revenue, Posts 15th Straight Quarter of Positive Operating Cash Flow

TerrAscend reported $65.5 million in net revenue for the first quarter of 2026, a 1.9% increase from the same period last year, while posting its 15th consecutive quarter of positive cash flow from continuing operations. The North American cannabis operator, which has operations in Pennsylvania, New Jersey, Maryland, Ohio and California, said gross profit for …

Continue reading

Minnesota Marijuana Sales Reach $25 Million in April, 2026 Total Tops $85 Million

Minnesota marijuana sales continued to climb in April, with licensed retailers selling around $25 million worth of products, according to newly released state data. The April total includes approximately $15 million in adult-use marijuana sales and $10 million in medical marijuana sales. That brings Minnesota’s 2026 total to roughly $85 million through the first four …

Continue reading

Massachusetts Cannabis Regulators to Host First EquityWorks Virtual Career Fair on May 20

Massachusetts marijuana regulators will host their first EquityWorks Virtual Cannabis Career Fair on May 20, offering job seekers a chance to connect with licensed businesses, receive career guidance and learn more about opportunities in the state’s legal marijuana industry. The event, hosted by the Massachusetts Cannabis Control Commission, will run from 10 a.m. to 4 …

Continue reading

Connecticut Legislature Sends Cannabis Bill Expanding Medical Access and Revising Hemp Rules to Governor

Connecticut lawmakers have sent Governor Ned Lamont a wide-ranging cannabis bill that would expand access to the state’s medical marijuana program, revise portions of its hemp laws and create new rules for infused beverages. House BIll 5350 was transmitted to Lamont today after the House concurred with Senate changes, clearing the final legislative hurdle for …

Continue reading

Green Thumb Reports $300 Million in Quarterly Revenue, 7.4% Increase From 2025

Green Thumb Industries reported $300.2 million in revenue in the first quarter of 2026, a 7.4% increase from the same period last year. The Chicago-based company, which owns RISE Dispensaries and manufactures cannabis brands including RYTHM, Dogwalkers, incredibles, Beboe, &Shine, Doctor Solomon’s and Good Green, reported $15.4 million in net income for the quarter, or …

Continue reading

Idaho Medical Marijuana Campaign Submits Over 150,000 Signatures, More Than Double Required to Make 2026 Ballot

An Idaho campaign to legalize medical marijuana has submitted more than 150,000 signatures across all 44 counties in an effort to place the Idaho Medical Cannabis Act before voters this November. The signatures were submitted by the May 1 deadline, according to Amanda Watson, communications lead for the Natural Medicine Alliance of Idaho. “After a …

Continue reading

High Tide Subsidiary Reports Record 7.6 Tonnes of Medical Marijuana Distributed in Germany

High Tide Inc. says its 51%-owned German subsidiary distributed a record 7.6 tonnes of medical marijuana during the company’s second fiscal quarter, marking another sign of rapid growth in Europe’s largest medical marijuana market. The Calgary-based company announced today that Remexian Pharma GmbH sold 7.6 tonnes of medical marijuana in Germany during the quarter ending …

Continue reading

Report: Congressional Research Service Says DOJ Medical Marijuana Order Could Ease 280E, Research Barriers

A new report from the Congressional Research Service says the Department of Justice’s recent order rescheduling certain medical marijuana products to Schedule III could have major implications for state-licensed medical marijuana businesses, patients, researchers and federal tax policy. The report analyzes DOJ’s April 23 final order, which moved marijuana and marijuana-derived products to Schedule III …

Continue reading

New Jersey Appeals Court Rules Police Officers Can’t Be Fired for Off-Duty Marijuana Use

A New Jersey appellate court has ruled that police officers cannot be fired solely for using marijuana while off duty, rejecting Jersey City’s argument that federal firearms law bars officers who consume cannabis from carrying department-issued weapons. The Superior Court of New Jersey, Appellate Division, issued the decision in Patten v. Jersey City Police Department, …

Continue reading